<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40930598</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1876-7605</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>17</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>JACC. Cardiovascular interventions</Title><ISOAbbreviation>JACC Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Comparison of Vascular Injury From Intravascular Lithotripsy, Cutting, or Ultra-High-Pressure Balloons During Coronary Calcium Modification.</ArticleTitle><Pagination><StartPage>2093</StartPage><EndPage>2104</EndPage><MedlinePgn>2093-2104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcin.2025.06.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1936-8798(25)01774-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Effective modification of heavily calcified coronary lesions is critical for successful percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL), cutting balloons (CBs), and ultra-high-pressure balloons (UHBs) are used commonly, yet data comparing their effectiveness and safety for calcified lesion modification remain unavailable.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to compare the effects of IVL, a CB, and a UHB on calcified coronary lesions in human cadaveric arteries, focusing on calcium fracture formation and vascular injury.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Seventeen calcified lesions from 6 cadavers were randomized to treatment with IVL (n = 5), the CB (n = 6), or the UHB (n = 6). Pre- and post-treatment optical coherence tomography, micro-computed tomography (CT), and histology were coregistered to evaluate calcium fractures and medial injury.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fractures confirmed by micro-CT and histology were observed in 80% of IVL-treated lesions, 66.7% treated with the CB, and 33.3% treated with the UHB (P = 0.350). Medial injury occurred significantly less frequently with IVL (20.0%) compared with the CB (83.3%) and the UHB (100%) (P = 0.012). In histologic sections with a calcium arc of &#x2265;180&#xb0;, IVL induced fractures in 100% of sections, all without medial injury, while the CB and UHB caused fractures without medial injury in 16.7% and 20.0% of sections, respectively (P = 0.007). For calcium arcs &lt;180&#xb0;, IVL produced fractures in 57.1% of sections, all without medial injury, compared with the CB (11.1% without medial injury) and UHB (0% without medial injury) (P = 0.008).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">IVL effectively modifies calcified lesions with less medial vascular injury compared with a CB and a UHB.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sekimoto</LastName><ForeName>Teruo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujiyoshi</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawakami</LastName><ForeName>Rika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madra</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Takamasa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Doosup</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St. Francis Hospital and Heart Center, Roslyn, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolff</LastName><ForeName>Eric H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>St. Francis Hospital and Heart Center, Roslyn, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraki</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamana</LastName><ForeName>Tomoyo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virmani</LastName><ForeName>Renu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Ziad A</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>St. Francis Hospital and Heart Center, Roslyn, New York, USA; New York Institute of Technology, Old Westbury, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finn</LastName><ForeName>Aloke V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, Maryland, USA; University of Maryland, School of Medicine, Baltimore, Maryland, USA. Electronic address: afinn@cvpath.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Cardiovasc Interv</MedlineTA><NlmUniqueID>101467004</NlmUniqueID><ISSNLinking>1936-8798</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008096" MajorTopicYN="Y">Lithotripsy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061205" MajorTopicYN="Y">Vascular Calcification</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055114" MajorTopicYN="N">X-Ray Microtomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057772" MajorTopicYN="Y">Vascular System Injuries</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002102" MajorTopicYN="N">Cadaver</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015906" MajorTopicYN="Y">Angioplasty, Balloon, Coronary</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062906" MajorTopicYN="Y">Cardiac Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calcification</Keyword><Keyword MajorTopicYN="N">intravascular lithotripsy</Keyword><Keyword MajorTopicYN="N">micro&#x2013;computed tomography</Keyword><Keyword MajorTopicYN="N">optical coherence tomography</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures This study was funded by the Guerci Foundation. CVPath Institute provided full support for this work. Dr Finn has received consulting fees and honoraria from Abbott Vascular, Amgen, Biosensors, Boston Scientific, CeloNova BioSciences, Cook Medical, Cardiovascular Systems, Lutonix Bard, Sinomed, and Terumo. Dr Virmani is a consultant for Abbott Vascular, Boston Scientific, CeloNova BioSciences, OrbusNeich Medical, Terumo, W.L. Gore &amp; Associates, Edwards Lifesciences, Cook Medical, Cardiovascular Systems, Recor Medical, Sino Medical Sciences Technology, Surmodics, and Bard BD. Drs Sekimoto, Fujiyoshi, Kawakami, Madra, Tanaka, Shiraki, Nakayama, Hamana, Virmani, and Finn are employees of CVPath Institute, which has received GranuResearch/Clinical Trial support from National Institutes of Health grant HL141425, a Leducq Foundation grant, 4C Medical, 4Tech, Abbott Vascular, Ablative Solutions. Absorption Systems, Advanced NanoTherapies, Aerwave Medical, Alivas, Amgen, Asahi Medical, Aurios Medical, Avantec Vascular, Becton Dickinson, Biosensors, Biotronik, Biotyx Medical, Bolt Medical, Boston Scientific, Canon USA, Cardiac Implants, Cardiawave, CardioMech, CeloNova BioSciences, Cerus EndoVascuIar, Chansu Vascular Technologies, the Children&#x2019;s National Medical Center, Concept Medical, Cook Medical, Cooper Health, Coramaze Technologies, CRL/AcceILab, Croivalve, Cardiovascular Systems, Dexcom, Edwards Lifesciences, Elucid Bioimaging, eLum Technologies, Emboline, Endotronix, Envision, Filterlex, Imperative Care, Innovalve, Innovative Cardiovascular Solutions, Intact Vascular, Interface Biologics, Intershunt Technologies, Invatin Technologies, Lahav CRO, Limflow, L&amp;J Biosciences, Lutonix, Lyra Therapeutics, the Mayo Clinic, Maywell, MD Start, MedAIIiance, Medanex, Medtronic, Mercator, MicroPort, MicroVention, Neovasc, Nephronyx, Nova Vascular, Nyra Medical, Occultech, Olympus, Ohio Health, OrbusNeich, Ossio, Phenox, Pi-Cardia, Polares Medical, Polyvascular, Profusa, ProKidney, Protembis, Pulse Biosciences, Qool Therapeutics, Recombinetics, Recor Medical, Regencor, Renata Medical, Restore Medical, Ripple Therapeutics, Rush University, Sanofi, Shockwave Medical, Sahajanand Medical Technologies, SoundPipe, Spartan Micro, SpectraWAVE, Surmodics, Terumo, the Jacobs Institute, Transmural Systems, Transverse Medical, TruLeaf Medical, the University of California-San Francisco, the University of Pittsburgh Medical Center, Vesper, Vetex Medical, Whiteswell, W.L. Gore &amp; Associates, and Xeltis. Dr Ali has received institutional grant support to St. Francis Hospital or OPCI from Abbott, Abiomed, Acist, Amgen, Boston Scientific, CathWorks, Canon, Conavi, Chiesi, HeartFlow, Inari, Medtronic, the National Institute of Health, Nipro, OpSens Medical, Medis Medical Imaging Systems, Philips, Shockwave Medical, Siemens, SpectraWAVE, and Teleflex; has received consulting fees from Boston Scientific, CathWorks, HeartFlow, OpSens Medical, Philips, and Shockwave Medical; and holds equity in Elucid, Lifelink, SpectraWAVE, and VitalConnect. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>10</Day><Hour>20</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40930598</ArticleId><ArticleId IdType="doi">10.1016/j.jcin.2025.06.035</ArticleId><ArticleId IdType="pii">S1936-8798(25)01774-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>